Overview

In this symposium, a renowned international faculty will provide contemporary narratives on: 

  • Venous thromboembolism (VTE) – the relationship between patient characteristics, the clinical presentation of VTE, the choice of anticoagulation/antithrombotic therapy (over the first 3 months of care and extended treatment), and outcomes
  • Burden of thrombosis in cancer patients (including VTE, arterial events, and bleeding-associated events with anticoagulation) and the prevention and treatment of cancer-associated thrombosis
  • Stroke prevention in patients with atrial fibrillation (AF)
  • Anticoagulation in patients with coronary or peripheral artery disease

Each presentation will review and provide perspectives based on:

  • The latest evidence from randomized controlled trials
  • Data from ongoing registries
  • Recommendations from the most recent clinical guidelines

Time will be dedicated to the discussion of some of the most challenging clinical scenarios using case histories to guide the debate and keypad voting to canvass the views of the audience.

View All Speakers

Speakers

A John Camm, MD, QHP, MD, FRCP, FACC, FESC


Professor, Clinical Cardiology St. George’s University of London Consultant Cardiologist St. George’s Hospital London, United Kingdom
View Full Bio

Alexander Turpie, MB, FRCP, FACP, FACC, FRCPC


Emeritus Professor, Medicine McMaster University Internist Hamilton Health Sciences Hamilton, Ontario, Canada
View Full Bio

Ajay Kakkar, BSc, MBBS, PhD, FRCS


Professor of Surgery University College London Chairman of University College London Partners Academic Health Science Partnership Director of the Thrombosis Research Institute London, United Kingdom
View Full Bio

Jeffrey Weitz, MD, FRCP(C), FACP


Professor of Medicine & Biochemistry McMaster University Executive Director, Thrombosis & Atherosclerosis Research Institute Hamilton, Ontario, Canada
View Full Bio

Howard Liebman, MD


Professor, Medicine Don Feinstein Chair, Hematology Keck School of Medicine of USC Los Angeles, California
View Full Bio

Freek W. A. Verheugt, MD, FACC, FAHA, FESC


Professor, Cardiology Heart-Lung Centre of the University Medical Centre of Nijmegen Chair, Cardiology Onze Lieve Vrouwe Gasthuis Amsterdam, The Netherlands
View Full Bio

Accreditation

CME

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Kentucky College of Medicine, and Thrombosis Research Institute. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this live activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care
  • Medical knowledge

Other

UK Healthcare CECentral certifies this activity for 2.25 hours of participation.

Acknowledgement

This activity is jointly provided by the University of Kentucky and Thrombosis Research Institute.

Supported by an unrestricted research grant from Bayer AG.

Background Materials

Several published papers are located under the Download Material button that may be useful as background reading for the symposium.

Online Modules

The precedings from the symposium presented at the satellite symposium, The Challenge of Anticoagulation: Getting Research Into Practice, preceding the 59th ASH Annual Meeting & Exposition in San Diego, California, on December 9, 2016, are available at TRI online modules.

FRONTLINE 2 Survey

The Fundamental Research in Oncology and Thrombosis (FRONTLINE 2) Survey is designed to evaluate how clinicians perceive the risk of venous thromboembolism in cancer patients and to provide insight into current strategies for thromboprophylaxis and management. It has been developed with the guidance of an international advisory board of experts in this field. This survey is coordinated by the Thrombosis Research Institute, London. It has been developed with the guidance of an international advisory board of experts in this field. All replies will be treated in the strictest confidence. The survey is split into 5 Sections (A-E) and will take approximately 20 - 30 minutes to complete.

To complete the survey, visit http://frontline2.tri-london.ac.uk/